Managing vasomotor symptoms in women after cancer

References

• Freeman EW, Sammel MD, Sanders RJ. Risk of long-term hot flashes after natural menopause: evidence from the Penn Ovarian Aging Study cohort. Menopause 2014;21:924–32
   PubMed Web of Science ®Google Scholar
• Huang AJ, Grady D, Jacoby VL. Persistent hot flushes in older postmenopausal women. Arch Intern Med 2008;168:840
   PubMed Web of Science ®Google Scholar
• Avis NE, Crawford SL, Greendale G, et al. Study of Women’s Health Across the Nation. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med 2015;175:531–9
   PubMed Web of Science ®Google Scholar
• Mekjavić IB, Sundberg CJ, Linnarsson D. Core temperature “null zone”. J Appl Physiol 1991;71:1289–95
   PubMed Web of Science ®Google Scholar
• Freedman R, Woodward S. Core body temperature during menopausal hot flushes. Fertil Steril 1996;66:1141–4
   Google Scholar
• Rance NE, Dacks PA, Mittelman-Smith MA, Romanovsky AA, Krajewski-Hall SJ. Modulation of body temperature and LH secretion by hypothalamic KNDy (kisspeptin, neurokinin B and dynorphin) neurons: a novel hypothesis on the mechanism of hot flushes. Front Neuroendocrinol 2013;34:211–27
   PubMed Web of Science ®Google Scholar
• Guthrie JR, Dennerstein L, Hopper JL, Burger HG. Hot flushes, menstrual status, and hormone levels in a population-based sample of midlife women. Obstet Gynecol 1996;88:437–42
   PubMed Web of Science ®Google Scholar
• Thurston RC, Ewing LJ, Low CA, Christie AJ, Levine MD. Behavioral weight loss for the management of menopausal hot flashes: a pilot study. Menopause 2015;22:59–65
   PubMed Web of Science ®Google Scholar
• Gold EB, Crawford SL, Shelton JF, et al. Longitudinal analysis of changes in weight and waist circumference in relation to incident vasomotor symptoms: the Study of Women’s Health Across the Nation (SWAN). Menopause 2017;24:9–26
   PubMed Web of Science ®Google Scholar
• Kroenke CH, Caan BJ, Stefanick ML, et al. Effects of a dietary intervention and weight change on vasomotor symptoms in the Women’s Health Initiative. Menopause 2012;19:980–8
   PubMed Web of Science ®Google Scholar
• Daley A, Stokes-Lampard H, Thomas A, MacArthur C. Exercise for vasomotor menopausal symptoms. Cochrane Database Syst Rev 2014;(11):CD006108
   PubMed Web of Science ®Google Scholar
• Bailey TG, Cable NT, Aziz N, et al. Exercise training reduces the frequency of menopausal hot flushes by improving thermoregulatory control. Menopause 2016;23:708–18
   PubMed Web of Science ®Google Scholar
• Speck RM, Courneya KS, Masse LC, et al. An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv 2010;4:87–100
   PubMed Web of Science ®Google Scholar
• The North American Menopause Society. Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society. Menopause 2015;22:1155–74
   PubMed Web of Science ®Google Scholar
• Geller SE, Shulman LP, van Breemen RB, et al. Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial. Menopause 2009;16:1156–66
   PubMed Web of Science ®Google Scholar
• Barton DL, Loprinzi CL, Quella SK, et al. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. JCO 1998;16:495–500
   PubMed Web of Science ®Google Scholar
• Franco OH, Chowdhury R, Troup J, et al. Use of plant-based therapies and menopausal symptoms: a systematic review and meta-analysis. JAMA 2016;315:2554–63
   PubMed Web of Science ®Google Scholar
• Daily JW, Ko BS, Ryuk J, Liu M, Zhang W, Park S. Equol decreases hot flashes in postmenopausal women: a systematic review and meta-analysis of randomized clinical trials. J Med Food 2019;22:127–39
   PubMed Web of Science ®Google Scholar
• Wang XP, Zhang DJ, Wei XD, Wang JP, Zhang DZ. Acupuncture for the relief of hot flashes in breast cancer patients: a systematic review and meta-analysis of randomized controlled trials and observational studies. J Can Res Ther 2018;14:600–8
   Web of Science ®Google Scholar
• Avis NE, Levine BJ, Danhauer S, Coeytaux RR. A pooled analysis of three studies of nonpharmacological interventions for menopausal hot flashes. Menopause 2019;26:350–6
   PubMed Web of Science ®Google Scholar
• Hunter MS, Liao K. Evaluation of a four-session cognitive behavioural intervention for menopausal hot flushes. Br J Health Psychol 1996;1:113–25
   Web of Science ®Google Scholar
• Atema V, van Leeuwen M, Oldenburg HSA, van Beurden M, Hunter MS, Aaronson NK. An internet-based cognitive behavioral therapy for treatment-induced menopausal symptoms in breast cancer survivors: results of a pilot study. Menopause 2017;24:762–7
   PubMed Web of Science ®Google Scholar
• Elkins GR, Fisher WI, Johnson AK, Carpenter JS, Keith TZ. Clinical hypnosis in the treatment of postmenopausal hot flashes: a randomized controlled trial. Menopause 2013;20:291–8
   PubMed Web of Science ®Google Scholar
• Cramer H, Lauche R, Paul A, Langhorst J, Kümmel S, Dobos GJ. Hypnosis in breast cancer care: a systematic review of randomized controlled trials. Integr Cancer Ther 2015;14:5–15
   PubMed Web of Science ®Google Scholar
• Barton DL, Schroeder KCF, Banerjee T, Wolf S, Keith TZ, Elkins G. Efficacy of a biobehavioral intervention for hot flashes: a randomized controlled pilot study. Menopause 2017;24:774–82
   PubMed Web of Science ®Google Scholar
• Goldstein KM, Shepherd-Banigan M, Coeytaux RR, et al. Use of mindfulness, meditation and relaxation to treat vasomotor symptoms. Climacteric 2017;20:178–82
   PubMed Web of Science ®Google Scholar
• Carpenter JS, Burns DS, Wu J, et al. Paced respiration for vasomotor and other menopausal symptoms: a randomized, controlled trial. J Gen Intern Med 2013;28:193–200
   PubMed Web of Science ®Google Scholar
• Nedrow A, Miller J, Walker M, Nygren P, Huffman LH, Nelson HD. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch Intern Med 2006;166:1453–65
   PubMed Web of Science ®Google Scholar
• Lee MS, Kim JI, Ha JY, Boddy K, Ernst E. Yoga for menopausal symptoms: a systematic review. Menopause 2009;16:602–8
   PubMed Web of Science ®Google Scholar
• Kenne Sarenmalm E, Martensson LB, Andersson BA, Karlsson P, Bergh I. Mindfulness and its efficacy for psychological and biological responses in women with breast cancer. Cancer Med 2017;6:1108–22
   PubMed Web of Science ®Google Scholar
• Carmody JF, Crawford S, Salmoirago-Blotcher E, Leung K, Churchill L, Olendzki N. Mindfulness training for coping with hot flushes: results of a randomized trial. Menopause 2011;18:611–20
   PubMed Web of Science ®Google Scholar
• Hardy C, Griffiths A, Norton S, Hunter MS. Self-help cognitive behavior therapy for working women with problematic hot flushes and night sweats (MENOS@Work): a multicenter randomized controlled trial. Menopause 2018;25:508–19
   PubMed Web of Science ®Google Scholar
• Sood R, Kuhle CL, Kapoor E, et al. Association of mindfulness and stress with menopausal symptoms in midlife women. Climacteric 2019 Jan 17. epub ahead of print
   PubMed Web of Science ®Google Scholar
• Lipov EG, Joshi JR, Sanders S, et al. Effects of stellate-ganglion block on hot flushes and night awakenings in survivors of breast cancer: a pilot study. Lancet Oncol 2008;9:523–32
   PubMed Web of Science ®Google Scholar
• Lipov EG, Joshi JR, Xie H, Slavin KV. Updated findings on the effects of stellate-ganglion block on hot flushes and night awakenings. Reflection and reaction. Lancet Oncol 2008;9:819–20
   PubMed Web of Science ®Google Scholar
• Rahimzadeh P, Imani F, Nafissi N, Ebrahimi B, Faiz S. Comparison of the effects of stellate ganglion block and paroxetine on hot flashes and sleep disturbance in breast cancer survivors. Cancer Manag Res 2018;10:4831–7
   PubMed Web of Science ®Google Scholar
• Simon JA, Portman DJ, Kaunitz AM, et al. Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials. Menopause 2013;20:1027–35
   PubMed Web of Science ®Google Scholar
• Suvanto-Luukkonen E, Koivunen R, Sundström H, et al. Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study. Menopause 2005;12:18–26
   PubMed Web of Science ®Google Scholar
• Archer DF, Seidman L, Constantine GD, Pickar JH, Olivier S. A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause. Am J Obstet Gynecol 2009;200:e1–10
   PubMed Web of Science ®Google Scholar
• Speroff L, Gass M, Constantine G, Olivier S. Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial. Obstet Gynecol 2008;111:77–87
   PubMed Web of Science ®Google Scholar
• Archer DF, Dupont CM, Constantine GD, Pickar JH, Olivier S. Desvenlafaxine for the treatment of vasomotor symptoms associated with menopause: a double-blind, randomized, placebo-controlled trial of efficacy and safety. Am J Obstet Gynecol 2009;200:238 e1–10
   PubMed Web of Science ®Google Scholar
• Joffe H, Guthrie KA, LaCroix AZ, et al. Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial. JAMA Intern Med 2014;174:1058–66
   PubMed Web of Science ®Google Scholar
• Bockbrader HN, Wesche D, Miller R, Chapel S, Janiczek N, Burger P. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet 2010;49:661–9
   PubMed Web of Science ®Google Scholar
• Guttuso T, Jr, Kurlan R, McDermott MP, Kieburtz K. Gabapentin’s effects on hot flashes in postmenopausal women: a randomized controlled trial. Obstet Gynecol 2003;101:337–45
   PubMed Web of Science ®Google Scholar
• Loprinzi CL, Sloan J, Stearns V, et al. Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis. JCO 2009;27:2831–7
   PubMed Web of Science ®Google Scholar
• Reddy SY, Warner H, Guttuso T, Jr., et al. Gabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trial. Obstet Gynecol 2006;108:41–8
   PubMed Web of Science ®Google Scholar
• Loprinzi L, Barton DL, Sloan JA, et al. Pilot evaluation of gabapentin for treating hot flashes. Mayo Clin Proc 2002;77:1159–63
   PubMed Web of Science ®Google Scholar
• Gidal BE, Radulovic LL, Kruger S, Rutecki P, Pitterle M, Bockbrader HN. Inter- and intra-subject variability in gabapentin absorption and absolute bioavailability. Epilepsy Res 2000;40:123–7
   PubMed Web of Science ®Google Scholar
• Pandya KJ, Morrow GR, Roscoe JA, et al. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet 2005;366:818–24
   PubMed Web of Science ®Google Scholar
• Santen RJ, Loprinzi CL. Nonhormonal treatments for menopausal symptoms – UpToDate. https://www.uptodate.com/contents/nonhormonal-treatments-for-menopausal-symptoms-beyond-the-basics, Dec 12, 2017 [last accessed 14 Mar 2019]
   Google Scholar
• Freedman RR, Roehrs TA. Effects of REM sleep and ambient temperature on hot flash-induced sleep disturbance. Menopause 2006;13:576–83
   PubMed Web of Science ®Google Scholar
• Loprinzi CL, Kugler JW, Barton DL, et al. Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5. J Clin Oncol 2007;25:308–12
   PubMed Web of Science ®Google Scholar
• Bordeleau L, Pritchard KI, Loprinzi CL, et al. Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors. JCO 2010;28:5147–52
   PubMed Web of Science ®Google Scholar
• Loprinzi CL, Qin R, Baclueva EP, et al. Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1. JCO 2010;28:641–7
   PubMed Web of Science ®Google Scholar
• Bockbrader HN, Radulovic LL, Posvar EL, et al. Clinical pharmacokinetics of pregabalin in healthy volunteers. J Clin Pharmacol 2010;50:941–50
   PubMed Web of Science ®Google Scholar
• Leon-Ferre RA, Novotny PJ, Wolfe EG, et al. Oxybutynin versus placebo for hot flashes: a randomized, double-blind clinical trial (ACCRU SC1603) San Antonio Breast Cancer Symposium 2018
   Google Scholar
• Sexton T, Younus J, Perera F, Kligman L, Lock M. Oxybutynin for refractory hot flashes in cancer patients. Menopause 2007;14:505–9
   PubMed Web of Science ®Google Scholar
• Simon JA, Gaines T, LaGuardia KD, Extended-Release Oxybutynin Therapy for VMS Study Group. Extended-release oxybutynin therapy for vasomotor symptoms in women: a randomized clinical trial. Menopause 2016;23:1214–21
   PubMed Web of Science ®Google Scholar
• Sica DA, Grubbs R. Transdermal clonidine: therapeutic considerations. J Clin Hypertension 2005;7:558–62
   Google Scholar
• Anderson RA, Skorupskaite K, Sassarini J. The neurokinin B pathway in the treatment of menopausal hot flushes. Climacteric 2019;22:51–4
   PubMed Web of Science ®Google Scholar
• Prague JK, Roberts RE, Comninos AN, et al. Neurokinin 3 receptor antagonism rapidly improves vasomotor symptoms with sustained duration of action. Menopause 2018;25:862–9
   PubMed Web of Science ®Google Scholar
• Skorupskaite K, George JT, Veldhuis JD, Millar RP, Anderson RA. Neurokinin 3 receptor antagonism reveals roles for neurokinin B in the regulation of gonadotropin secretion and hot flashes in postmenopausal women. Neuroendocrinology 2018;106:148–57
   PubMed Web of Science ®Google Scholar
• Sassarini J, Skorupskaite K, McLean J, et al. NK3R antagonist reduces flush frequency and alters connectivity in the salience network. Proceedings of the International Menopause Society World Congress on Menopause, Vancouver, 2018; Abstract 7840
   Google Scholar
• Coelingh Bennink HJT, Verhoeven C, Zimmerman Y, Visser M, Foidart JM, Gemzell-Danielsson K. Pharmacokinetics of the fetal estrogen estetrol in a multiple-rising-dose study in postmenopausal women. Climacteric 2017;20:285–9
   PubMed Web of Science ®Google Scholar
• Genazzani AR, Gaspard U, Foidart JM. Oral investigational drugs currently in phase I or phase II for the amelioration of menopausal symptoms. Expert Opin Investig Drugs 2019;28:235–47
   PubMed Web of Science ®Google Scholar
• Gerard C, Mestdagt M, Tskitishvili E, et al. Combined estrogenic and anti-estrogenic properties of estetrol on breast cancer may provide a safe therapeutic window for the treatment of menopausal symptoms. Oncotarget 2015;6:17621–36
   PubMed Web of Science ®Google Scholar
• Stuenkel CA, Davis SR, Gompel A, et al. Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2015;100:3975–4011
   PubMed Web of Science ®Google Scholar